NCJ Number
181426
Date Published
July 2000
Length
103 pages
Annotation
This report provides an overview of 1999 ADAM (Arrestee Drug Abuse Monitoring) Program findings and detailed site-by-site tables on drug use among booked arrestees.
Abstract
In 1999, the ADAM Program collected data from more than 30,000 adult male arrestees in 34 sites and from more than 10,000 adult female arrestees in 32 sites. Additionally, data were collected from more than 2,500 juvenile male detainees in nine sites and more than 400 juvenile female detainees in six sites. The level of recent drug use among 1999 ADAM arrestees was substantial. Every site reported that at least 50 percent of adult male arrestees tested positive for at least one drug. These consistently high percentages of overall use mask differences in trends for specific drugs and in specific segments of the arrestee population. In 27 of the 34 sites, more than 60 percent of the adult male arrestees tested positive for the presence of at least one of the NIDA-5 drugs, ranging from 50 percent in San Antonio to 77 percent in Atlanta. For female adult arrestees, the median rate for use of any drug was 67 percent compared to 64 percent in 1998. Among adult males, marijuana was the drug most often detected in 24 of the 34 reporting sites, and cocaine was the drug most likely to be detected in the other 10 sites. Among adult females arrestees, cocaine was the drug most often detected in 25 of 32 sites. In the remaining sites, marijuana was the most frequently detected drug (four sites) followed by methamphetamine (three sites). Multiple drug use was evident among arrestees in some of the ADAM sites. Extensive tabular and graphic data
Date Published: July 1, 2000
Downloads
Similar Publications
- A Practitioner’s Guide to Evaluating Prosecutor-Led Diversion Programs
- FY 2024 Solicitation Overview: Edward Byrne Memorial Justice Assistance Grant (JAG) Program—State Solicitation
- Implementation of Electronic Health Record Integration and Clinical Decision Support to Improve Emergency Department Prescription Drug Monitoring Program Use